Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • News item (1)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) June 2023 (1)
  • March 2026 (1)
  • July 2025 (1)
  • November 2024 (1)
  • July 2024 (1)
  • June 2024 (1)
  • April 2024 (1)
  • July 2023 (1)
  • April 2023 (1)
  • September 2022 (1)
  • June 2022 (1)
  • April 2022 (1)
  • June 2020 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • (-) Sexually transmitted infections (STIs) (1)
  • Tobacco (9)
  • International (3)
  • Population screening programs in the Caribbean Netherlands (2)
  • Consumer exposure to chemical substances (1)
  • Health research for COVID-19 (1)
  • Public Health Monitors (1)

1 search results

You searched for these word(s): risk assessment
  • More STIs diagnosed in 2022, most significant increase in gonorrhoea

    https://www.rivm.nl/en/news/more-stis-diagnosed-in-2022-most-significant-increase-in-gonorrhoea

    … drug that prevents HIV. MSM and other persons at increased risk of HIV can take part in a pilot where they receive …

    Publication date: 06-22-2023

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon